Here's what you need to know about Gilead's 'flopped' Remdesivir drug trial

CNBC's Kelly Evans is joined by Stat News' Adam Feurstein, who reported on a Gilead's Remdesivir's flopped trials to treat coronavirus, to discuss the report as stocks slashed earlier gains on Thursday.
Thu, Apr 23 20201:28 PM EDT